Clinical Trial

Acute Caffeine Intake and Velocity Metrics

Study acronym: CAF+Vel
Completed
View on ClinicalTrials.gov →
Summary
The purpose of this study was to determine whether the acute ergogenic effects of caffeine differ according to the velocity metric used to assess strength performance against different relative loads. Thirteen resistance-trained men completed a triple-blind, randomized, placebo-controlled, crossover study. Participants ingested either caffeine (3 mg·kg-1) or a placebo 60 min before performing bench press and back squat exercises at 25%, 50%, 75%, and 90% of one-repetition maximum (1RM). Mean velocity (MV) and mean propulsive velocity (MPV) were simultaneously recorded using a linear position transducer
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-07-08.
Trial Details
NCT Number NCT07701395
Lead Sponsor University of Alcala
Conditions Caffeine and Resistance Exercise
Enrollment 13 participants
Start Date 2025-01-01
Primary Completion 2025-06-01 (estimated)
Study Completion 2025-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-15